| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.6M | +19.5% |
| SG&A Expense | $5.2M | +4.7% |
| Operating Income | -$13.2M | -14.4% |
| Pre-tax Income | -$13.2M | -17.3% |
| Income Tax | $0 | — |
| Net Income | -$13.2M | -17.3% |
| EPS (Basic) | -$4.56 | -1528.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Inventory | $2.6M | +105.9% |
| Current Assets | $8.5M | -29.5% |
| Total Assets | $9.3M | -28.0% |
| Current Liabilities | $1.7M | +10.4% |
| Long-term Debt | $366K | -33.1% |
| Total Liabilities | $2.1M | -1.0% |
| Stockholders' Equity | $7.2M | -33.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | -14.8% |
| Capital Expenditures | $203K | +350.2% |
| Investing Cash Flow | -$203K | -350.2% |
| Financing Cash Flow | $8.4M | -37.3% |
| Free Cash Flow | -$13.0M | -16.2% |